• Info
  • Insider Ownership

Insider Trading & Ownership of David Patience

Location
Tucson, AZ
Summary
The estimated net worth of David Patience is at least $1,169,176 dollars as of 23 Feb 2026. David Patience is the Chief Financial Officer of TriSalus Life Sciences, Inc. and owns shares of TriSalus Life Sciences, Inc. (TLSI) stock worth about $1.1M. David Patience is the Chief Financial Officer of Accelerate Diagnostics, Inc and owns shares of Accelerate Diagnostics, Inc stock worth about $67.7K.
Signature
/s/ David Patience
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow David Patience and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • David Patience has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,169,176.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: TriSalus Life Sciences, Inc. ($1,101,493).
  • Past-year value change for that position: +$14,994.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of David Patience

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TLSI, TLSIW TriSalus Life Sciences, Inc. Chief Financial Officer $1,101,493 +$14,994 +1.4% 23 Feb 2026
AXDX Accelerate Diagnostics, Inc Chief Financial Officer $67,683 01 Apr 2025

Insider Transactions Reported by David Patience:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.